NewSelf Tirzepatide Review: Cost, a Verified Seal & Honest Verdict (2026)

NewSelf has a genuine LegitScript seal (#43278346) served directly from LegitScript's own CDN, alongside a flat all-doses price with no escalation as you titrate up. Every fact here comes from the company's own published program.

What NewSelf is

NewSelf is a telehealth platform, offering compounded semaglutide+ (with B12/Glycine) and tirzepatide+ (with B6/Glycine), sourced from 503A licensed pharmacies. LegitScript certified. It also publishes third-party potency, sterility, and endotoxicity testing, and covers 48 states plus Puerto Rico.

What NewSelf costs

Semaglutide+ starts from $99.97/month — among the lowest prices this site has documented — and tirzepatide+ from $144.49/month. All dosages are priced the same, so there's no cost escalation as your dose increases.

The brand-vs-compounded question

NewSelf dispenses compounded semaglutide and tirzepatide only — no brand-name option. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

NewSelf's real strengths: a genuinely verified LegitScript seal, plus 503A-sourced pharmacies, published third-party testing, all-doses-flat pricing, and broad 48-state-plus-Puerto-Rico coverage. The trade-offs: not available in Mississippi or Louisiana, it's compounded only with no brand-name pathway, and the site's broader AI health-optimization and longevity platform is worth knowing about if you want a narrower GLP-1-only focus. As with any GLP-1 program, confirm your state's coverage during intake; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

NewSelf's genuinely verified LegitScript seal, 503A sourcing, and flat all-doses pricing are real strengths this review confirmed directly — among the strongest transparency combinations here at this price point. For another genuinely LegitScript-verified provider at a similarly low starting price, compare it against MyFastRx or CoreAge Rx. For a provider with an aggressive first-month price whose LegitScript claim this review couldn't reconfirm live due to a rate limit, see NuvaHealth. For a low-cost microdose option paired with a genetic-panel upsell of uncertain value, see PlexusDx. For a provider whose own headline price this review found directly contradicts its actual itemized floor, see Royal Medical Center. For another provider with a similarly misleading headline — a single Georgia clinic, not a national service — see Southern Vitality and Weight Loss. For a provider this review confirmed has three contradicting cancellation windows across its own site, see Sumbare Wellness. See our best tirzepatide providers ranking for the full field.